11,088 results on '"Takeuchi, T."'
Search Results
452. High-field performance and structure of (Nb,Ta)3Sn superconductors produced by Ta-Sn core
453. Superconducting properties and rapid heating condition in transformed jelly-roll Nb3A1 multifilamentary wires as a function of maximum ohmic-heating temperature
454. Mise à jour de l’analyse intégrée de la tolérance du filgotinib (FIL) chez les patients atteints de polyarthrite rhumatoïde (PR) active modérée à sévère recevant un traitement (TT) sur une période médiane de 2,2 ans
455. Le cancer dans les programmes d’essais cliniques sur l’upadacitinib dans la polyarthrite rhumatoïde, le rhumatisme psoriasique et la spondylarthrite ankylosante
456. Efficacité à long terme du baricitinib chez des patients atteints de polyarthrite rhumatoïde qui ont présenté une réponse inadéquate aux csDMARD : résultats à 7 ans de l’étude RA-BEYOND
457. Risk of human infection with Giardia duodenalis from cats in Japan and genotyping of the isolates to assess the route of infection in cats
458. AB0384 MEDICATION USE IN SYSTEMIC LUPUS ERYTHEMATOSUS – DATA FROM A MULTICENTRE COHORT STUDY
459. FRI0219 MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS IN REAL WORLD DATA
460. THU0217 UPADACITINIB MONOTHERAPY IN METHOTREXATE-NAÏVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM SELECT-EARLY
461. OP0128 DISTINCT FEATURES OF HLA-DR+ AND HLA-DR- PD-1HI CXCR5- T PERIPHERAL HELPER CELLS IN SEROPOSITIVE RHEUMATOID ARTHRITIS
462. FRI0497 THERAPEUTIC STRATEGIES AND LONG-TERM OUTCOME IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES: A SINGLE CENTER LARGE-SCALE OBSERVATIONAL COHORT STUDY
463. SAT0093 CDAI AND DAS28 IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE
464. THU0204 A SUBGROUP ANALYSIS OF LOW DISEASE ACTIVITY AND REMISSION FROM PHASE 3 STUDY OF FILGOTINIB IN PATIENTS WITH INADEQUATE RESPONSE TO BIOLOGIC DMARDS
465. OP0025 DRUG RETENTION OF 7 BIOLOGICS AND TOFACITINIB IN BIOLOGICS-NAÏVE AND BIOLOGICS-SWITCHED PATIENTS WITH RHEUMATOID ARTHRITIS -THE ANSWER COHORT STUDY
466. SAT0113 DISCORDANCE OF CLINICAL REMISSION AND IMAGING REMISSION BY ULTRASONOGRAPHY IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH BIOLOGIC AGENTS
467. THU0045 IDENTIFICATION OF NOVEL CENTROMERE AUTOANTIGENS IN SJÖGREN’S SYNDROME, SYSTEMIC SCLEROSIS AND PRIMARY BILIARY CHOLANGITIS.
468. FRI0139 FILGOTINIB PROVIDED RAPID AND SUSTAINED RELIEF OF PAIN AND FATIGUE AND IMPROVED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC DMARDS: RESULTS FROM THE FINCH 2 STUDY
469. THU0049 DISTINCT EXPRESSION OF COINHIBITORY MOLECULES ON ALVEOLAR T CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS- AND IDIOPATHIC INFLAMMATORY MYOPATHIES-ASSOCIATED INTERSTITIAL LUNG DISEASE
470. THU0114 CERTOLIZUMAB PEGOL IN PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED EFFICACY ANALYSIS OF PHASE 3 CLINICAL TRIALS ACROSS BASELINE RHEUMATOID FACTOR QUARTILES
471. THU0202 INTEGRATED SAFETY ANALYSIS OF FILGOTINIB TREATMENT FOR RHEUMATOID ARTHRITIS FROM 7 CLINICAL TRIALS
472. FRI0079 CHARACTERISTICS OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS
473. AB1103 AUTOMATIC FINGER JOINT BONE EROSION SCORE PREDICTION CONSIDERING 2-TIME-POINT X-RAYS OF PATIENTS WITH RHEUMATOID ARTHRITIS BY DEEP LEARNING
474. FRI0123 SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 8.4 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS
475. FRI0505 TOCILIZUMAB DISCONTINUATION AFTER REMISSION ACHIEVEMENT IN PATIENTS WITH ADULT STILL’S DISEASE
476. Ferromagnetic 2/1 quasicrystal approximants
477. Crystal structure of E.coli DNA gyrase B in complex with 2-oxo-1,2-dihydroquinoline derivative
478. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
479. Observational and theoretical constraints on the formation and early evolution of the first dust grains in galaxies at 5 < z < 10
480. Magnetic Microscopy Using a Circularly Polarized Hard-X-ray Nanoprobe at SPring-8
481. Preparation of suppressor column for capillary ion chromatography with conductivity detection
482. Hard x-ray photoemission spectroscopy of rhenium substituted higher manganese silicides
483. Quasi-one-dimensional magnetic interactions and conduction electrons in EuCu5 and EuAu5 with the characteristic hexagonal structure
484. P372 Effects of filgotinib on anaemia, thrombocytopenia and leukopenia: Phase 3 study results in patients with active rheumatoid arthritis and prior inadequate response/intolerance to biological DMARDs
485. Comparative Study of International Major Codes for the Seismic Design of Buildings
486. Hybridization Effect on Electron Transport Properties of Rhombic Triacontahedral-Type Al60-xMg40Xx. (X = Zn, Cu, Ag, and Pd) 1/1-Cubic Approximants
487. Structural Studies of Al55 Si7Cu25.5 Fe12.5 1/1-Cubic Approximant By Means of X-Ray Rietveld, Method and Haadf-Stem
488. Serum soluble Fas/APO-1 is increased in patients with primary Sjögren's syndrome
489. Neutron activation analysis of ivory of African elephants
490. Crystallography of BCC Precipitates at Grain Boundary Corners in FCC Matrix
491. Amino acids, peptides.
492. Origin of multiple peak photoluminescence in InGaN/GaN multiple quantum wells
493. Discovery of Small-Scale Spiral Structures in the Disk of SAO 206462 (HD 135344B)(exp 1): Implications for the Physical State of the Disk from Spiral Density Wave Theory
494. Involvement of MIP3a-CCR6 axis in the recruitment of Th17 precursors to the lesions of Behcetʼs disease: 0369
495. The addition of another disease-modifying anti-rheumatic drug, bucillamine, to methotrexate in place of infliximab improves the rate of infliximab-free sustained remission: 0147
496. Abatacept provides clinical efficacy in Japanese patients with active RA: a multi-center, randomized, double-blinded, controlled bridging trial in Japan: 0588
497. A phase I study to evaluate the safety, tolerability and efficacy of abatacept in Japanese rheumatoid arthritis patients: 0364
498. Abatacept demonstrated long-term safety and efficacy in active ra patients who showed inadequate response to methotrexate: an analysis of the Japanese phase iii open-label, long-term extension trial: 0032
499. Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study
500. The fate of the interstellar medium in early-type galaxies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.